Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Nov;70(3):475–480. doi: 10.1111/j.1476-5381.1980.tb08726.x

Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat.

A V Juorio
PMCID: PMC2044360  PMID: 6777007

Abstract

1 The concentrations of p- and m-tyramine, dopamine, 3,4-dihydroxyphenylacetic acid and homo-vanillic acid were measured in the mouse or rat striatum following the subcutaneous injection of molindone or fluphenazine. The mouse hypothalamic levels of the m- or p-isomers of octopamine were also analysed. 2 Endogenous concentrations of p- and m-tyramine in the mouse striatum and p- and m-octopamine in the mouse hypothalamus were 20.6, 5.7, 9.4 and 1.2 ng/g respectively. The rat striatum concentrations of p- and m-tyramine were 12.8 and 3.8 ng/g. 3 The administration of low doses of molindone (1 to 10 mg/kg) produced a reduction in striatal p-tyramine, an increase in m-tyramine and an increase in dopamine turnover. Similar effects were produced by all doses of fluphenazine (0.1 to 5 mg/kg) employed. These findings are consistent with those observed after blockade of dopamine postsynaptic receptors. 4 With high doses of molindone (100 mg/kg) the effects on both tyramines and on dopamine metabolism were reversed. These results can be interpreted as molindone acting as a partial agonist. 5 The concentrations of hypothalamic p- and m-octopamine were increased by the higher doses of molindone (20 to 100 mg/kg) employed while lower doses produced no significant effects. All doses of fluphenazine reduced hypothalamic p-octopamine. These changes seem to depend on differences in the availability of p-tyramine to be converted into p-octopamine. 6 These results suggest that molindone acts as a blocker or a partial agonist of dopamine receptor sites and fit well with the proposal of a reciprocal relation between dopamine and tyramine. It is not possible yet to ascertain whether tyramine controls dopamine or vice versa or if it is a direct or a more remote relation.

Full text

PDF
475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDEN N. E., ROOS B. E., WERDINIUS B. On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method. Life Sci. 1963 Jul;(7):448–458. doi: 10.1016/0024-3205(63)90132-2. [DOI] [PubMed] [Google Scholar]
  2. Boulton A. A., Juorio A. V. The tyramines: are they involved in the psychoses? Biol Psychiatry. 1979 Apr;14(2):413–419. [PubMed] [Google Scholar]
  3. Brandau K., Axelrod J. The biosynthesis of octopamine. Naunyn Schmiedebergs Arch Pharmacol. 1972;273(1):123–133. doi: 10.1007/BF00508085. [DOI] [PubMed] [Google Scholar]
  4. Bunney B. S., Roth R. H., Aghajanian G. K. Effects of molindone on central dopaminergic neuronal activity and metabolism: similarity to other neuroleptics. Psychopharmacol Commun. 1975;1(4):349–358. [PubMed] [Google Scholar]
  5. Burt D. R., Enna S. J., Creese I., Snyder S. H. Dopamine receptor binding in the corpus striatum of mammalian brain. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4655–4659. doi: 10.1073/pnas.72.11.4655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CARLSSON A., LINDQVIST M. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. Acta Pharmacol Toxicol (Copenh) 1963;20:140–144. doi: 10.1111/j.1600-0773.1963.tb01730.x. [DOI] [PubMed] [Google Scholar]
  7. Clark M. L., Huber W. K., Sakata K., Fowles D. C., Serafetinides E. A. Molindone in chronic schizophrenia. Clin Pharmacol Ther. 1970 Sep-Oct;11(5):680–688. doi: 10.1002/cpt1970115680. [DOI] [PubMed] [Google Scholar]
  8. Danielson T. J., Boulton A. A., Robertson H. A. m-Octopamine, p-octopamine and phenylethanolamine in rat brain: a sensitive, specific assay and the effects of some drugs. J Neurochem. 1977 Dec;29(6):1131–1135. doi: 10.1111/j.1471-4159.1977.tb06519.x. [DOI] [PubMed] [Google Scholar]
  9. Gilder D. A., Fain W., Simpson L. L. A comparison of the abilities of chlorpromazine and molindone to interact adversely with guanethidine. J Pharmacol Exp Ther. 1976 Aug;198(2):255–263. [PubMed] [Google Scholar]
  10. Juorio A. V., Danielson T. J. Effect of haloperidol and d-amphetamine on cerebral tyramine and octopamine levels. Eur J Pharmacol. 1978 Jul 1;50(1):79–82. doi: 10.1016/0014-2999(78)90256-x. [DOI] [PubMed] [Google Scholar]
  11. Juorio A. V. Drug-induced changes in the formation, storage and metabolism of tyramine in the mouse. Br J Pharmacol. 1979 Jul;66(3):377–384. doi: 10.1111/j.1476-5381.1979.tb10841.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Juorio A. V. Effect of chlorpromazine and other anti-psychotic drugs on mouse striatal tyramines. Life Sci. 1977 May 15;20(10):1663–1667. doi: 10.1016/0024-3205(77)90340-x. [DOI] [PubMed] [Google Scholar]
  13. Juorio A. V. Effect of stress and L-DOPA administration on mouse striatal tyramine and homovanillic acid levels. Brain Res. 1979 Dec 21;179(1):186–189. doi: 10.1016/0006-8993(79)90505-5. [DOI] [PubMed] [Google Scholar]
  14. Juorio A. V. Effects of D-amphetamine and antipsychotic drug administration on striatal tyramine levels in the mouse. Brain Res. 1977 Apr 22;126(1):181–184. doi: 10.1016/0006-8993(77)90227-x. [DOI] [PubMed] [Google Scholar]
  15. LAVERTY R., SHARMAN D. F. MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN. Br J Pharmacol Chemother. 1965 Jun;24:759–772. doi: 10.1111/j.1476-5381.1965.tb01632.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. LAVERTY R., SHARMAN D. F. THE ESTIMATION OF SMALL QUANTITIES OF 3,4-DIHYDROXYPHENYLETHYLAMINE IN TISSUES. Br J Pharmacol Chemother. 1965 Apr;24:538–548. doi: 10.1111/j.1476-5381.1965.tb01744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Molinoff P. B., Landsberg L., Axelrod J. An enzymatic assay for octopamine and other beta-hydroxylated phenylethylamines. J Pharmacol Exp Ther. 1969 Dec;170(2):253–261. [PubMed] [Google Scholar]
  18. Murphy G. F., Robinson D., Sharman D. F. The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse. Br J Pharmacol. 1969 May;36(1):107–115. doi: 10.1111/j.1476-5381.1969.tb08308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. O'Keeffe R., Sharman D. F., Vogt M. Effect of drugs used in psychoses on cerebral dopamine metabolism. Br J Pharmacol. 1970 Feb;38(2):287–304. doi: 10.1111/j.1476-5381.1970.tb08517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Philips S. R., Davis B. A., Durden D. A., Boulton A. A. Identification and distribution of m-tyramine in the rat. Can J Biochem. 1975 Jan;53(1):65–69. doi: 10.1139/o75-010. [DOI] [PubMed] [Google Scholar]
  21. Philips S. R., Durden D. A., Boulton A. A. Identification and distribution of p-tyramine in the rat. Can J Biochem. 1974 May;52(5):366–373. doi: 10.1139/o74-055. [DOI] [PubMed] [Google Scholar]
  22. Reis D. J., Molinoff P. B. Brain dopamine- -hydroxylase: regional distribution and effects of lesions and 6-hydroxy-dopamine on activity. J Neurochem. 1972 Jan;19(1):195–204. doi: 10.1111/j.1471-4159.1972.tb01269.x. [DOI] [PubMed] [Google Scholar]
  23. Roos B. E. Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat. J Pharm Pharmacol. 1969 Apr;21(4):263–264. doi: 10.1111/j.2042-7158.1969.tb08243.x. [DOI] [PubMed] [Google Scholar]
  24. Rubin A. A., Yen H. C., Pfeffer M. Psychopharmacological profile of molindone. Nature. 1967 Nov 11;216(5115):578–579. doi: 10.1038/216578a0. [DOI] [PubMed] [Google Scholar]
  25. Saavedra J. M. Enzymatic-isotopic method for octopamine at the picogram level. Anal Biochem. 1974 Jun;59(2):628–633. doi: 10.1016/0003-2697(74)90316-9. [DOI] [PubMed] [Google Scholar]
  26. Seeman P., Chau-Wong M., Tedesco J., Wong K. Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4376–4380. doi: 10.1073/pnas.72.11.4376. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES